RHY — Rhythm Biosciences Income Statement
0.000.00%
Last trade - 00:00- AU$18.72m
- AU$14.42m
- AU$0.05m
Annual income statement for Rhythm Biosciences, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | AAS | AAS | AAS | AAS | AAS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0.046 | 0.014 | 0.025 | 0.228 | 0.052 |
| Cost of Revenue | |||||
| Gross Profit | -1.35 | -2.18 | -0.172 | -0.327 | -2.59 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 4.06 | 7.73 | 11.2 | 11.5 | 8.6 |
| Operating Profit | -4.02 | -7.72 | -11.2 | -11.3 | -8.54 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -4.02 | -6.61 | -8.79 | -8.22 | -6.86 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -4.02 | -6.61 | -8.79 | -8.22 | -6.86 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -4.02 | -6.61 | -8.79 | -8.22 | -6.86 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -4.02 | -6.61 | -8.79 | -8.22 | -6.86 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.04 | -0.035 | -0.041 | -0.037 | -0.017 |